Latest 10-K annual reports

Playboy, Inc. reported a significant reduction in net loss for fiscal year 2025, driven by increased licensing revenue and a strategic shift to a capital-light business model, despite ongoing internal control weaknesses.

SmartFinancial, Inc. reported a significant increase in net income and record loan and deposit growth for 2025, alongside strategic capital management and a focus on cybersecurity.

Teads Holding Co. reported a significant net loss of $517.1 million in 2025, driven by a major acquisition, goodwill impairment, and restructuring charges, despite substantial revenue growth.

Franklin BSP Capital Corporation's 2025 annual report highlights increased investment income and a diversified portfolio, alongside net realized and unrealized losses and ongoing market uncertainties.

Greystone Housing Impact Investors LP reported a net loss of $7.6 million in 2025 and identified a material weakness in its internal controls over financial reporting.

Capital Bancorp, Inc. announced an 84.6% surge in net income to $57.2 million for 2025, driven by the IFH acquisition and organic growth, despite rising nonperforming assets and an internal control weakness.

ATN International, Inc. reported a significantly narrowed net loss in 2025, driven by reduced operating expenses and strategic shifts in its US Telecom segment, alongside ongoing network modernization and a planned tower portfolio sale.

Holley Inc. reported a significant turnaround in 2025, achieving net income and substantial gross margin improvement, driven by operational efficiencies and higher pricing.

Flotek Industries, Inc. reported a significant increase in total revenues and net income for the fiscal year ended December 31, 2025, driven by growth in both Chemistry Technologies and Data Analytics segments.

Oragenics, Inc. reports continued operating losses and a going concern doubt, while advancing its lead mild traumatic brain injury drug candidate, ONP-002, into Phase 2a clinical trials in Q1 2026.

Siddhi Acquisition Corp, a SPAC, reported a net loss of $223,387 for the year ended December 31, 2025, as it continues its search for a business combination target.

HF Foods Group Inc. reported a net loss of $38.8 million for 2025, an improvement from the prior year, alongside a full goodwill impairment and strategic operational expansions.

Douglas Elliman Inc. reported a significant turnaround in 2025, achieving net income and positive operating income, driven by the strategic sale of its property management business and increased average transaction values.

Rapid7, Inc. filed an Amendment No. 1 to its Annual Report on Form 10-K for fiscal year 2025 to include an inadvertently omitted Compensation Recoupment Policy.

First Foundation Inc. reported a net loss of $155.2 million for 2025, alongside a pending merger with FirstSun Capital Bancorp and identified material weaknesses in internal controls.

Silvercrest Asset Management Group Inc. reported a 1.3% revenue increase to $125.3 million in 2025, but net income declined significantly by 48.7% to $8.06 million, driven by increased expenses and net client outflows.

Ludwig Enterprises, an early-stage genomic diagnostics company, reported significant losses and a going concern warning in its 2025 annual report, despite advancing its Revealia Breast test towards a Q2 2026 trial launch.

CSB Bancorp, Inc. announced a 33.5% increase in net income to $13.4 million for 2025, driven by higher net interest income and improved credit loss expense.

Universal Logistics Holdings, Inc. reported a substantial net loss and operating loss for 2025, driven by impairment charges and a material weakness in financial reporting.

Once Upon a Farm, PBC announced a 53% increase in net sales for 2025, reaching $240.7 million, driven by product innovation and expanded distribution, while narrowing its net loss and completing a significant IPO.

Ardent Health, Inc. reported a 6.0% revenue increase in 2025 but saw net income decline significantly due to surging professional liability costs and the impact of new federal healthcare legislation.

Perspective Therapeutics, a radiopharmaceutical developer, reported significant R&D investment and clinical progress for its alpha-particle therapies, alongside a recent $175 million capital raise, despite continued net losses.

Dell Technologies reported a 19% increase in net revenue for Fiscal 2026, reaching $113.5 billion, primarily fueled by significant demand for AI-optimized servers and disciplined cost management.

Samsara Inc. reported a significant reduction in net loss and robust revenue growth for fiscal year 2026, driven by increased customer adoption and expanded platform usage.

Kyntra Bio, formerly FibroGen, completed the sale of its China operations for $220.4 million, significantly improving liquidity while advancing its oncology and myelodysplastic syndromes pipeline.

Getty Images reports a significant net loss in 2025, driven by substantial litigation and merger-related costs, despite overall revenue growth and strategic debt management.

FutureFuel Corp. reported a significant 61% revenue drop and a net loss in 2025, primarily due to regulatory uncertainty in its Biofuels segment and operational challenges in Chemicals.

The Arena Group Holdings, Inc. reported a significant turnaround in 2025, achieving net income from continuing operations of $28.6 million and a working capital surplus, driven by increased digital revenue and reduced operating costs.

Babcock & Wilcox Enterprises, Inc. significantly improved its financial performance in 2025, reducing net losses and securing a major $2.4 billion natural gas power plant project, while addressing prior going concern doubts.

Eagle Financial Services reports a strategic 2025, marked by a successful capital raise and investment portfolio repositioning, despite a GAAP net income decline driven by one-time losses.